The store will not work correctly when cookies are disabled.
(E)-2-(2-(6,7-Dihydroquinolin-8(5H)-ylidene)hydrazinyl)-benzo[d]thiazole
ID: ALA4794734
PubChem CID: 122461995
Max Phase: Preclinical
Molecular Formula: C16H14N4S
Molecular Weight: 294.38
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: c1cnc2c(c1)CCC/C2=N\Nc1nc2ccccc2s1
Standard InChI: InChI=1S/C16H14N4S/c1-2-9-14-12(7-1)18-16(21-14)20-19-13-8-3-5-11-6-4-10-17-15(11)13/h1-2,4,6-7,9-10H,3,5,8H2,(H,18,20)/b19-13+
Standard InChI Key: GYINVIIQVGQIDJ-CPNJWEJPSA-N
Molfile:
RDKit 2D
21 24 0 0 0 0 0 0 0 0999 V2000
13.2246 -10.4954 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
13.1406 -9.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8838 -9.3506 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4316 -9.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0230 -10.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4316 -11.3753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2488 -11.3753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6574 -10.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2488 -9.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4315 -9.2764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.7224 -9.6850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3084 -10.5022 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5993 -10.9108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8902 -10.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8902 -9.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5993 -9.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5993 -8.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3084 -8.0506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0134 -8.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0134 -9.2764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3084 -9.6850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
5 6 2 0
10 11 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
12 21 1 0
16 21 2 0
11 20 2 0
2 10 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.38 | Molecular Weight (Monoisotopic): 294.0939 | AlogP: 3.84 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.17 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.23 | CX Basic pKa: 3.33 | CX LogP: 4.39 | CX LogD: 4.38 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.73 | Np Likeness Score: -1.72 |
References
1. Chen G,Niu C,Yi J,Sun L,Cao H,Fang Y,Jin T,Li Y,Lou C,Kang J,Wei W,Zhu J. (2019) Novel Triapine Derivative Induces Copper-Dependent Cell Death in Hematopoietic Cancers., 62 (6.0): [PMID:30835473] [10.1021/acs.jmedchem.8b01996] |